The WACC of Beam Therapeutics Inc (BEAM) is 8.3%.
| Range | Selected | |
| Cost of equity | 7.20% - 9.40% | 8.30% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 7.50% | 7.25% |
| WACC | 7.2% - 9.4% | 8.3% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.72 | 0.81 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.20% | 9.40% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 7.00% | 7.50% |
| After-tax WACC | 7.2% | 9.4% |
| Selected WACC | 8.3% | |